title: Genome Filtering for New DNA Biomarkers of Loa loa Infection Suitable for Loop-Mediated Isothermal Amplification.
abstract: Loa loa infections have emerged as a serious public health problem in patients co-infected with Onchocerca volvulus or Wuchereria bancrofti because of severe adverse neurological reactions after treatment with ivermectin. Accurate diagnostic tests are needed for careful mapping in regions where mass drug administration is underway. Loop-mediated isothermal amplification (LAMP) has become a widely adopted screening method because of its operational simplicity, rapidity and versatility of visual detection readout options. Here, we present a multi-step bioinformatic pipeline to generate diagnostic candidates suitable for LAMP and experimentally validate this approach using one of the identified candidates to develop a species-specific LAMP assay for L. loa. The pipeline identified ~140 new L. loa specific DNA repeat families as putative biomarkers of infection. The consensus sequence of one family, repeat family 4 (RF4), was compiled from ~ 350 sequences dispersed throughout the L. loa genome and maps to a L. loa-specific region of the long terminal repeats found at the boundaries of Bel/Pao retrotransposons. PCR and LAMP primer sets targeting RF4 specifically amplified L. loa but not W. bancrofti, O. volvulus, Brugia malayi, human or mosquito DNA. RF4 LAMP detects the DNA equivalent of one microfilaria (100 pg) in 25-30 minutes and as little as 0.060 pg of L. loa DNA (~1/1600th of a microfilaria) purified from spiked blood samples in approximately 50 minutes. In summary, we have successfully employed a bioinformatic approach to mine the L. loa genome for species-specific repeat families that can serve as new DNA biomarkers for LAMP. The RF4 LAMP assay shows promise as a field tool for the implementation and management of mass drug administration programs and warrants further testing on clinical samples as the next stage in development towards this goal.
authors.affiliation: New England Biolabs, Ipswich, Massachusetts, United States of America.
authors.forename: Catherine B
authors.initials: CB
authors.lastname: Poole
authors.affiliation: New England Biolabs, Ipswich, Massachusetts, United States of America.
authors.forename: Laurence
authors.initials: L
authors.lastname: Ettwiller
authors.affiliation: New England Biolabs, Ipswich, Massachusetts, United States of America.
authors.forename: Nathan A
authors.initials: NA
authors.lastname: Tanner
authors.affiliation: New England Biolabs, Ipswich, Massachusetts, United States of America.
authors.forename: Thomas C
authors.initials: TC
authors.lastname: Evans
authors.affiliation: Research Foundation in Tropical Diseases and Environment, Buea, Cameroon.
authors.forename: Samuel
authors.initials: S
authors.lastname: Wanji
authors.affiliation: New England Biolabs, Ipswich, Massachusetts, United States of America.
authors.forename: Clotilde K S
authors.initials: CK
authors.lastname: Carlow
mesh_terms: D000818:Animals; D015415:Biomarkers / Q000378:metabolism; D019295:Computational Biology; D018509:DNA, Helminth / Q000097:blood / Q000235:genetics*; D049751:Genome, Helminth; D006801:Humans; D008117:Loa / Q000235:genetics*; D008118:Loiasis / Q000097:blood / Q000175:diagnosis* / Q000469:parasitology*; D016133:Polymerase Chain Reaction; D012680:Sensitivity and Specificity; D013045:Species Specificity
chemical_list: D015415:Biomarkers; D018509:DNA, Helminth